GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Tax Expense

Cathay Biotech (SHSE:688065) Tax Expense : ¥50 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Tax Expense?

Cathay Biotech's tax expense for the months ended in Mar. 2024 was ¥17 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥50 Mil.


Cathay Biotech Tax Expense Historical Data

The historical data trend for Cathay Biotech's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Tax Expense Chart

Cathay Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial 76.99 63.45 90.94 83.34 40.39

Cathay Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.35 23.01 8.61 1.42 16.94

Cathay Biotech Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech  (SHSE:688065) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Cathay Biotech Tax Expense Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cathay Biotech (SHSE:688065) Business Description

Traded in Other Exchanges
N/A
Address
1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines